Tetec AG   Report issue

For profit Phase 3
Founded: Reutlingen Germany (2000)

Organization Overview

First Clinical Trial
2012
NCT01640457
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Tetec AG | TETEC AG Reutlingen